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Uracil arises in cellular DNA by hydrolytic cytosine (C) deamination and by erroneous repli-
cative incorporation of deoxyuridine monophosphate opposite adenine. The former event is 
devastating by generation of C  thymine transition mutations, causing cancer, aging and neu-
rodegenerative diseases, if uracil is not removed by uracil-DNA glycosylase (UDG) and re-
placed by cytosine through downstream base excision repair (BER) proteins before replication. 
The most important human UDG is hUNG, with hSMUG1 as back-up. During immunoglobulin 
gene diversification in activated B cells, targeted deamination by activation-induced cytidine 
deaminase (AID) followed by uracil excision by hUNG is important for class switch recombi-
nation (CSR) and somatic hypermutation (SHM) by providing DNA double strand breaks and 
mutagenesis, respectively. hSMUG1 may substitute for hUNG in CSR, but its role in CSR and 
SHM is largely unclear. The aim of this investigation was to determine hSMUG1 excision ac-
tivity for uracil in R-loop DNA, the product of AID and formed during transcription, and com-
pare it to that in bubble U-DNA, which is formed transiently in cellular processes as e.g. DNA 
replication. The results show that hSMUG1 excises uracil in bubble more efficient than in R-
loop DNA, indicating a back-up UDG function rather than a specific function during CSR/SHM 
and/or transcription. hSMUG1 also function in ribosomal and telomerase RNA quality control 
by e.g. regulating the presence of base modifications, and binds the major pseudouridine syn-
thase in mammals DKC1, where the (non-catalytic) Ser26 and Glu35 residues participate. The 
results show that hSMUG1 S26R/E35D mutant protein excises uracil in R-loop slightly more 
efficient than in DNA bubble, i.e., close to the opposite of wild type hSMUG1, suggesting 
altered enzyme function. hSMUG1 Pro240 is part of the His239–Lys249 intercalating loop be-
ing inserted into the damaged site in the DNA double helix. The hSMUG1 P240G protein ex-
cised uracil in R-loop much more efficient than in DNA bubble, demonstrating significantly 
altered enzyme function. Thus, while wild type hSMUG1 excised uracil in DNA bubble signif-
icantly more efficient than in R-loop, this was completely reversed regarding the hSMUG1 
P240G mutant protein, indicating a role of Pro240 in stabilizing the hSMUG1–bubble U-DNA 
complex, or inhibiting the hSMUG1–R-loop U-DNA complex. When compared to results on 
hUNG from another research group member, hSMUG1 excises uracil in R-loop DNA more 
than two orders of magnitude less efficient than hUNG.   
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Because the maintenance of genomic integrity is of utmost importance to all living organisms, 
they have developed different molecular mechanisms to repair damaged DNA. In mammals 
including humans, an inability to eliminate different kinds of DNA damage brings about a broad 
spectrum of pathologies, for example, neuronal deficits, immune-deficiencies, premature aging 
and cancer. The most abundant type of DNA damage is chemical base modifications including 
base removal by hydrolysis, which happens at the rate of several thousand base pairs per cell 
per day in humans. In addition to water, base damages are caused by endogenous metabolic and 
immune processes rather than environmental toxins, aside from the ultraviolet (UV) damage to 
the skin from sunlight and a multitude of different damages to lung and blood from cigarette 
smoke (1-3). 
 
1.1 Hydrolytic DNA damages 
 
1.1.1 The abundance and mutagenicity of uracil necessitate its removal from DNA 
 
Uracil (U) arises spontaneously in cellular DNA by hydrolytic deamination of cytosine (C), and 
by misincorporation of deoxyuridine monophosphate (dUMP) rather than incorporation of thy-
midine monophosphate (dTMP) opposite adenine (A) during replication. Deamination of cyto-
sine has been estimated to happen at a rate of 60–500 events per day in human cells (1). The 
non-blocking nature of uracil makes it highly mutagenic causing C → thymine (T) transition 
mutations if not repaired before replication. Misincorporated uracil is not miscoding, however, 
may alter binding of certain proteins to DNA (4). The consideration that cells must possess an 
ability to eliminate uracil from DNA, prompted the discovery of an enzyme capable of cleaving 





Figure 1. Introduction and fate of uracil in DNA. The left circle represents misincorporation of 
dUMP during replication resulting in the A:U pair. The right circle represents the spontaneous deami-
nation of cytosine leading to formation of the G:U mispair. In both cases, human uracil-DNA glyco-
sylases, i.e. hUNG, hSMUG1 and hTDG, recognize uracil and initiate the base excision repair (BER) 
pathway to restore the correct base. Reproduced from (6). 
 
1.1.2 The deamination products uracil and thymine are corrected by repair enzymes.  
The extracyclic amino group at cytosine C4 position is unstable to hydrolysis and lost slowly 
at physiological pH to form uracil. The proposed major chemical mechanisms for this involves 
protonation at the cytosine N3 position followed by direct nucleophilic attack by OH– at the C4 
position and the subsequent elimination of the amino group (7). In addition to cytosine, the 
other bases in DNA also deaminate losing their exocyclic amine and contribute to spontaneous 
mutagenesis in human cells. Thus, adenine, guanine (G) and 5-methylcytosine (m5C) convert 
to hypoxanthine, xanthine and thymine, respectively. However, C and m5C are the most fre-
quently deaminated, where m5C is deaminated 3–4 times more frequently than C. Importantly, 
deamination events happen at a much higher frequency in single-stranded DNA (ssDNA) than 
in double-stranded DNA (dsDNA), and are thus exacerbated in transient ssDNA regions during 
replication, transcription and recombination. While deaminated cytosine is rapidly removed 
from DNA by an uracil-DNA glycosylase (UDG; e.g., the highly efficient family 1 UDG, see 
below), the G:T mispair resulting from deamination of m5C is a substrate for the thymine-DNA 
glycosylase (TDG) and the relatively slow mismatch repair (MMR) process. Therefore, the G:C 
→ A:T transitions at the CpG sequences account for one-third of the single site mutations re-





1.1.3 Enzymatic deamination  
 
Enzymatic deamination of cytosine at the immunoglobulin gene loci by activation-induced cyt-
idine deaminase (AID) starts the antigen-dependent antibody diversification processes by initi-
ating class switch recombination (CSR) and somatic hypermutation (SHM) in B cells (9). Ab-
errant or elevated levels of AID in such cells may thus contribute to mutagenesis and cancer. 
An enzyme with similar activity, APOBEC1 (apolipoprotein B mRNA editing enzyme catalytic 
polypeptide 1), mediates host defense against retroviruses.  
 
1.2 Oxidative damages 
Reactive oxygen species (ROS) are the typical byproducts of the electron transport chain during 
respiration in aerobic organisms, and are also products of catabolic oxidases, anabolic processes 
and peroxisomal metabolism. At low levels, ROS perform important cellular functions such as 
serving as messengers in redox signaling reactions and effecting defense responses to invading 
pathogens as an important part of the immune system. However, ROS cause a total of 100 
different oxidative base lesions and 2´-deoxyribose modifications. Usually, the deleterious con-
sequences of ROS are reduced in cells by  the restriction of respiration to the mitochondrial 
compartment, DNA complexed and protected by histones and the extinguishing of surplus ROS 
by the antioxidant enzymes superoxide dismutase, catalase, and peroxiredoxin (10). Despite 
this, an excess of ROS is related to the development of human diseases, such as cancer, Alz-
heimer’s disease, Parkinson’s disease, diabetes, and heart failure. The most conspicuous of the 
ROS are the superoxide radical, hydrogen peroxide (H2O2) and the hydroxyl radical (•OH), the 
latter produced by the Fenton reaction when Fe2+ reacts with H2O2 (11,12). 
 
A major and biologically significant ROS-formed base from guanine is 7,8-dihydro-8-oxogua-
nine (Fig. 8C), which mispairs with adenine thereby adding to the overall mutational load. In 
addition, it oxidizes further to other deleterious secondary DNA lesions due to its low oxidation 
potential (13). As the most reactive ROS, •OH is damaging to most cellular constituents and 
adds to the double bonds of the DNA bases and abstracts hydrogen atoms from their methyl 
groups, as well as it attacks the sugar residue in their immediate vicinity (14). For example, 
thymine glycol (Fig. 8C) and several ring-opened and ring-fragmented products is generated 
from a •OH attack on the C5–C6 double bonds of thymine. Attack on its methyl group results 







Figure 2. Common DNA base lesions. (A) Normal structures of DNA bases: adenine, guanine, cytosine 
and thymine. (B) Deaminated bases: hypoxanthine, xanthine, uracil and thymine arising from deamina-
tion of exocyclic bases of adenine, guanine, cytosine and 5-methylcytosine, respectively. (C) Oxidized 
DNA bases: formamidopyrimidine derivative of adenine, 7,8-dihydro-8-oxoguanine and thymine gly-
col. (D) Methylated DNA bases: N3-methyladenine, N7-methylguanine, O⁶-methylguanine, N3-
methylcytosine, O⁴-methylthymine, O⁴-ethylthymine and N3-methylthymine. Figures from (3). 
 
 
Aside from attacking the DNA bases, ROS compromise the DNA backbone by causing single 
strand breaks (SSB) estimated to be 2300/cell/h in mammals. Breaks in the DNA backbone are 




1.3 Bases damaged by alkylation 
 
Several distinct alkylation repair pathways have developed to counteract both endogenous and 
exogenous alkylation, providing the cell with a diverse arsenal to protect its DNA from such 
damage. While the causes of endogenous alkylation damage are unknown, S-adenosylmethio-
nine has been shown to methylate DNA (i.e., non-enzymatically) at a biologically important 
level and is consequently able to cause the simplest type of DNA alkylation damage: the addi-
tion of a single methyl group to a DNA base.  Indeed, twelve different base lesions can be 
produced in DNA by methylating agents reacting with ring nitrogen or oxygen atoms. The most 
common methylation product is N7-methylguanine (Figure 2), which accounts for about 75% 
of all methylated base lesions in DNA. While N7-methylguanine is rather innocuous on its own, 
it is susceptible to depurination resulting in an apurinic/apyrimidinic (AP) site, which can be 
toxic and mutagenic. Many of the remaining lesions, such as N3-methyladenine or N1-methyl-
adenine (Figure 2), are naturally cytotoxic because they inhibit replicative DNA polymerases 
(Pols). Three different repair pathways, at least, are involved in the repair of methylation dam-
age: direct demethylation by O6-methylguanine DNA methyltransferase, and oxidative demeth-
ylation by the AlkB enzyme family, as well as base excision repair (16).  
 
1.4 Base excision repair 
 
The base excision repair (BER) pathway corrects most DNA base damages before they reach 
causing mutagenicity or toxicity, and is consequently operating in both actively replicating and 
non-replicating cells. First enzymatic step in BER is typically excision of an aberrant or dam-
aged base from dsDNA by a DNA glycosylase, which catalyzes the cleavage of the N-glyco-
sidic bond between the base and the 2´-deoxyribose creating an AP site. To facilitate recogni-
tion, glycosylases appear to pinch gently while scanning the DNA, ultimately bending it at the 
position of the damaged base to create a widened and flattened minor groove. This localized 
DNA distortion promotes the damaged base to flip out of the double helix (base flipping) and 
enter the binding site of the enzyme for surveying and protein-substrate complex formation 
(17). DNA glycosylases are classified as mono-functional or bi-functional based on their ina-
bility or ability, respectively, to execute AP lyase strand cleavage activity. The mono-functional 
glycosylases utilize a water molecule as a nucleophile to attack the C´1 of deoxyribose to pro-
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mote base release, generating an AP site product that is identical to that formed upon spontane-
ous DNA depurination or depyrimidination. This AP site is a substrate for an AP endonuclease, 
which breaks the phosphodiester bond of DNA. The bi-functional glycosylases utilize an active 
site amine moiety as a nucleophile to excise the damaged base and generate a covalent Schiff 
base protein-DNA intermediate during the catalytic process. The result may be incision of the 
DNA strand within the phosphodiester linkage 3´ to the AP site, either by β-elimination or by 
two consecutive (β,δ) elimination steps (enzymes performing this are also called tri-functional), 
creating a single-strand break (SSB) with a non-conventional 3´-terminus. 
 
Normally, after base removal by a DNA glycosylase, an AP endonuclease incises the DNA 
backbone immediately 5´ to the AP site to generate a strand break with a priming 3´-OH group 
and a 5´-deoxyribose phosphate (dRP) remnant. The major AP endonuclease in mammals is 
APE1, which accounts for more than 95% of the total cellular AP site incision activity. APE1 
catalyzes an acid-base hydrolytic reaction to incise the phosphodiester (P–O) bond of DNA, 
which is promoted by Mg2+. Aside from its primary AP endonuclease activity, APE1 can cata-
lyze the removal of 3´-blocking ends generated by bi-functional DNA glycosylases, ROS and 
other DNA damaging agents by its 3´-phosphodiesterase activity (18-21).  
 
To replace the excised nucleotide, organisms utilize Pols to execute repair synthesis. A Pol 
requires a 3´-OH terminus on the primer strand, and ideally an unmodified template to incor-
porate the correct complementary deoxynucleotide(s). Many Pols also have 3´ to 5´ exonuclease 
(proofreading) activity that removes non-complementary or altered nucleotides immediately 
after phosphodiester bond formation and before the addition of another nucleotide. Polβ is the 
main human Pol that works on short nucleotide gaps, for example, those that emerge during 
short-patch BER/repair (SPR) which typically involves the incorporation of only a single nu-
cleotide. In that case Polβ simultaneously removes the 5´-dRP by its lyase function and prepares 
for the final ligation step. In some instances, e.g. if the 5´-dRP is modified and resistant to being 
removed by Polβ, a replicative Pol is recruited to continue synthesis several nucleotides down-
stream. A displaced DNA strand (a flap) is generated, which is removed by the flap endonucle-
ase 1 (FEN1), also preparing for ligation. This is called long-patch BER/repair (LPR). The final 
step in BER is catalyzed by the DNA ligase LIG1, which also is the main DNA ligase in chro-
mosomal replication, and/or the LIG3α/XRCC1 complex, which is primarily involved in SPR; 
both are dependent on ATP as cosubstrate (Figure 3). However, the exact molecular basis for 
choosing SPR (or LPR) over the other is unclear. For example, the presence or absence of some 
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Pols and cofactors, the type of initiating lesion, different protein–protein interactions, the cell 
cycle stage, or whether the cell is terminally differentiated or actively dividing, all appear to 
have an impact on the final decision. The decision also seems to be influenced, at least in part, 
by the relative ATP concentration after 5´-dRP removal. If the ATP concentration is high, BER 
is likely to proceed immediately to ligation by LIG3α. Alternatively, LPR will occur more fre-
quently at low ATP concentration where ligation is less favored (4,22-25).  
 
1.4.1 Uracil-DNA glycosylases 
 
Uracil and some uracil analogs formed by oxidation of cytosine and thymine are excised from 
the genome by UDGs. Mammalian cell nuclei contains at least four UDGs; UNG2 (uracil-N-
glycosylase 2), SMUG1 (single-strand-specific monofunctional UDG), TDG and MBD4 (me-
thyl-CpG binding domain protein 4). UNG2 and SMUG1 are the enzymes responsible for repair 
of spontaneously deaminated cytosine (26), while post-replicative excision of misincorporated 
dUMP (U:A) and excision of AID-generated uracil (U:G) are performed mainly by UNG2 alone 
(27). UNG is profoundly specific for processing uracil in DNA, yet also inefficiently excises 5-
fluorouracil (FU), a common cancer chemotherapeutic agent (28). Interactions with the repli-
cation clamp PCNA (proliferating cell nuclear antigen) and the ssDNA- binding protein RPA 
(replication protein A) indicate recruitment of UNG2 to sites of DNA synthesis, where its pri-
mary function is to rapidly excise uracil incorporated opposite adenine (29). E. coli Ung (5) 
turned out to be the founding member of a large superfamily of UDGs (30), which currently 
includes six subfamilies, three of which are present in Eukarya. In addition to UNG itself (fam-
ily 1/UNG family), these include the mismatch-specific UDG (family 2/Mug family; TDG in 
mammals) (31) and SMUG1 (family 3/SMUG family) (32). Despite a considerable amino acid 
sequence divergence, all UDGs share a common αβ-fold-structured catalytic domain (33). The 
family 2 UDGs emerged with the identification of TDG, an enzyme capable of excising thymine 
from G:T mismatches. Regardless, the family was named after the E. coli Mug protein (31) 
crediting that the G:U rather than the G:T mismatch is the most efficient substrate for the mem-
bers of this subfamily. In contrast to UNG, the family 2 glycosylases have a spacious and rather 
non-discriminating active site pocket, accommodating a broad range of substrates including 
pyrimidine derivates like FU, 5-hydroxymethyluracil (hmU) and 3,N4-ethenocytosine (34). 
However, these substrates are excised at an extremely low turnover rate (35). Compared to 






Figure 3. The mammalian base excision repair pathway. The four steps of BER is divided into; 
damage recognition and removal; strand incision and end trimming; nucleotide insertion; ligation. The 
continuation of BER is then either short-patch repair (SPR) or long-patch repair (LPR). The method is 
often chosen by what type of cell of BER is initiated in, where LPR is often located in proliferating cells 






core only, TDG contains additional N-and C-terminal areas providing non-specific DNA inter-
action and regulatory functions (36). Additional subfamilies of UDGs appear to have evolved 
in archaeal and bacterial organisms thriving under extreme environmental conditions such as 




The uracil-excising activity ascribed to the SMUG family was initially identified in Xenopus 
laevis, insect and human cells (32), and was thought to be present in vertebrates and insects 
only (37). Vertebrates contain both SMUG1 and UNG, yet their roles as UDGs are still not 
completely understood. At the beginning it was believed that SMUG1 mainly served as a back-
up for UNG (38), but subsequent discoveries of other activities and interactions have prompted 
investigations into other biological functions. When first discovered in X. laevis, the xSMUG1 
enzyme was characterized as “single-strand-selective” which indeed resulted in its name (32). 
Unfortunately, overlooking the strong feedback inhibition of the AP site in the initial charac-
terization of xSMUG failed to show its actually higher activity for U:G and U:A than for U in 
ssDNA (38). 
 
Like TDG, SMUG1 excises FU from DNA, which, in contrast to TDG, appears to protect cells 
from the cytotoxic effects of the drug, as shown by siRNA knockdown experiments (39). Inter-
estingly, a hmU-DNA glycosylase activity originally discovered in calf thymus was later iden-
tified as SMUG1 (40). Since hmU is the deamination product of 5-hydroxymethylcytosine, 
which has been recognized both as an intermediate substrate in the m5C demethylation pathway 
as well as an epigenetic marker itself, SMUG1 may be involved in epigenetic regulation. How-
ever, hmU is also a common ROS-induced DNA damage, and together with the activity for 
other abundant oxidized pyrimidines like 5-hydroxyuracil and fU demonstrated by SMUG1 
(41) it is now believed to play a significant role in the repair of oxidized bases. 
 
Recently, our research group demonstrated that hSMUG1 is able to incise the AP site after 
uracil removal, which results in a 3´-α,β-unsaturated aldehyde (designated uracil-DNA incision 
product, UIP) and a 5´-phosphate. UIP is removed from the 3´-end by hAPE1. hSMUG1 also 
incises DNA or processes UIP to a 3´-phosphate (designated uracil-DNA processing product, 






Figure 4.  Proposed human BER pathway. After uracil has been removed by the DNA glycosylase 
activity of SMUG1 (step 1; blue), the latter is either replaced by APE1 (dark red) which incises the AP 
site (step 2a), or SMUG1 itself incises the AP site (step 2b; red) leaving behind a 3´-α,β-unsaturated 
aldehyde (UIP) which can be removed by APE1 (step 3b). Further processing of UIP (or maybe an 
alternative type of incision of the AP site; green broken arrows) results in a 3´-phosphate (UPP) which 
is a substrate for PNKP (orange). The cleaned one nucleotide gap in DNA is now ready for insertion of 
the correct dCMP (step 4) by the repair DNA polymerase β (Pol β; dark blue), which also exhibits the 
dRP lyase activity which removes the 5´-dRP remnant (step 3a) after APE1 incision. BER is concluded 
by nick-sealing (step 5) by DNA ligase III (LIG3; purple). The residues removed are indicated in dark 
red; those resulting from replacement in dark blue, respectively; dR, deoxyribose. From (42). 
 
During immunoglobulin gene diversification in activated B cells, targeted cytosine deamination 
by AID followed by uracil excision by hUNG (4) is important for CSR and SHM by providing 
the substrate for DNA double strand breaks and mutagenesis, respectively (44), where SMUG1 
also may be involved (27,45). However, considerable uncertainty remains regarding the mech-
anisms leading to DNA incision following uracil excision, but based on the general BER 
scheme an AP endonuclease (APE1 and/or APE2) is believed to be required for strand-break 
formation (Figure 5, right square). Although a substantial residual CSR level (~20%) has been 
demonstrated present in cells in the absence of both APE1 and APE2, suggesting that other 
enzymes may contribute DNA nicking activity (46). The finding in our research group that 























































Figure 5. UNG-mediated DNA incision in CSR. This working model suggests how removal of AID-
generated uracil followed by incision of the AP site by UNG and nick processing by exonuclease 1 
(EXO1) form double-stranded breaks in immunoglobulin switch regions. Transcription of the targeted 
immunoglobulin gene region forms bubbles in DNA, so granting AID access to ssDNA (stabilized by 
RPA) to deaminate C to U. This results in UNG recruitment (by RPA) and uracil excision. According 
to our results (left square), UNG (with SMUG1 as a backup) is able to incise the AP site, leaving behind 
a 5´-phosphate which is a better substrate for exonuclease 1 (EXO1) 5´→ 3´ digestion than the 5´-deox-
yribose phosphate left behind by APE1 incision (right square). This model relies on the MMR compo-
nent MutSα (MSH2/6), which recognizes an U:G mismatch and recruits EXO1. This also applies to 
ssDNA patch generation by EXO1 in SHM. , increased. From reference (43). 
 
lowing uracil excision, may obviate the need of involving AP endonucleases in explaining the 
molecular mechanism of UNG and SMUG1 in CSR, and opens up a possibility that SMUG1 













































explain the reported dispensability of APE enzymes in SHM through providing MMR complex 
accessibility at an earlier stage.  
 
 
Figure 6. hSMUG1 active site interactions. DNA structure in black; protein amino acid residues in 
green; catalytic water in blue; P, protein; R, amino acid residue. Red unbroken line, ionic interaction; 
red dotted line, hydrogen bond; black dotted line, H bond between cognate bases; brown unbroken line, 
van der Waals interaction. Courtesy of Svein Bjelland.  
 
1.4.2.1 Structure of hSMUG1 explains its base recognition 
  
The SMUG family exhibits only limited amino-acid sequence similarity with members of the 
other UDG subfamilies and the conservation seems restricted to catalytic site residues, showing 
mosaic features of the UNG and MUG enzymes. Crystallographic analysis of xSMUG1 recog-
nized a pyrimidine-binding pocket topologically similar to those of other UDGs, and implicated 
a water displacement/replacement mechanism to account for its preference for uracil over thy-
mine. In the crystal structure of xSMUG1 in complex with uracil-containing dsDNA, the en-
zyme detached from the AP site product and rebound to the DNA ends. Such behavior was also 
observed with the substrate analog 1-[2´-deoxy-2´-fluoro-β-D-arabinofuranosyl]-uracil (βFU). 

















































































































points towards the pyrimidine specificity pocket of the xSMUG1. Upon replacing the 5´-end 
cytosine base with βFU, a mixed population of extrahelical cleaved AP sites and βFU in a pro-
ductive orientation in the active site was observed. Two motifs, the minor groove intercalation 
loop (xSMUG1 251-PSPRN-225) and the short α helix unique to the SMUG1 family (xSMUG1 
256-PQANK-260), are inserted as a wedge into the DNA duplex, flipping the scissile nucleotide 
through the major groove as for the family 1 and 2 UDGs. However, penetration of both motifs 
into the base stack creates a more extensive disruption of the dsDNA than seen for the other 
enzymes in the UDG family. A conserved Arg254 (Arg243 in hSMUG1; Figure 6) occupies 
the gap left behind from the flipped-out base, whereas a Pro from the unique α helix pushes into 
the base stack on the distal strand. At the SMUG1 protein bound to the 3´-end of the damage-
containing strand, the base pairing remained intact and the active site was accessible to solvent. 
This fact was exploited when free uracil and hmU was soaked into the crystal, which revealed 
a rather remarkable mechanism for achieving pyrimidine specificity in SMUG1. The uracil N3-
imino and O4 carbonyl moieties hydrogen bond to Asn174 (Asn163 in hSMUG1; Figure 5) 
side chain, and O2 accepts a hydrogen bond from Met95 main chain NH group and imidazole 
ring of His250 (His239 in hSMUG1; Figure 6). This hydrogen bonding pattern implies that 
cytosine is rejected by SMUG1 in a manner analogous to that for UNG (47). 
 
 
 1.4.2.2 SMUG1 is involved in telomerase RNA processing and RNA quality control 
Telomerase is a specialized ribonucleoprotein (RNP) complex that extends telomeric repeats at 
the ends of chromosomes (48). The telomerase holoenzyme comprises three main subunits: the 
telomerase reverse transcriptase (hTERT), the telomerase RNA component (hTERC) and a 
complex of the major pseudouridine synthase in mammals dyskerin (DKC1) (DKC1, NHP2, 
NOP1, and GAR1) (49). hTERC biogenesis is a multistep process, initiated by transcription of 
the primary transcript by RNA polymerase II that can extend several hundred nucleotides down-
stream of the hTERC gene body (50). SMUG1 regulates the presence of base modifications 
(51) and interacts with hTERC, which is required for co-transcriptional processing of the nas-
cent transcript into mature hTERC. It is the highly structured non-coding RNA that carries the 
complementary template of the telomeric repeat sequence and two H/ACA domains that bind 
to dyskerin (52). The hTERC/dyskerin RNP complex and hTERT associate in both nucleoli and 
Cajal bodies during S phase, suggesting that both these subnuclear structures are involved in 
the biogenesis and trafficking of the telomerase complex (53,54). In the nucleoli ribosomal 
RNA (rRNA) synthesis and processing, rather than DNA metabolism, takes place. Subsequent 
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end-processing steps lead to the formation of the 451 nucleotides long mature hTERC (50). 
Loss of SMUG1 leads to an imbalance between mature hTERC and its processing intermedi-
ates, resulting in accumulation of 3´-polyadenylated and 3´-extended intermediates that are de-
graded in an EXOSC10-independent RNA degradation pathway (51).   
 
SMUG1 interacts and co-localizes with DKC1, and associates with the 47S rRNA precursor, 
which is a major substrate of DKC1. hSMUG1 amino acids 25–35 and 220–233 were indicated 
as potential DKC1-binding sequences, while the DKC1 peptides consisting of amino acids 16–
29, 112–122, 247–260, 400–410 and 475–491 were indicated as potential binding sequences to 
hSMUG1. Molecular modeling indicates involvement of hSMUG1 Glu29 and Glu33, and 
DKC1 Arg110 and Arg111, and furthermore hSMUG1 Glu231, in the interaction surface. 
Eventually, site-directed mutagenesis demonstrated that hSMUG1 amino acids 29, 33 and 231 
are required for binding to DKC1 (Table 1). It is important to note that interaction with DKC1 
does not obstruct SMUG1 activity, nor does interaction with SMUG1 obstruct DKC1 activity. 
Loss of SMUG1 leads to rRNA processing defects and accumulation of hmU in rRNA. 
hSMUG1 excises hmU from a single deoxyribose moiety placed in single-stranded RNA in 
vitro, suggesting that the enzyme may excise hmU from RNA in vivo. hSMUG1 does not excise 




Table 1. Function of hSMUG1 amino acid residues 
Residue Function Reference 
Ala14 RNA  
Ala16 RNA  
Gly25 rRNA quality control: putatively binds DKC1 (55) 
Ser26 rRNA quality control: putatively binds DKC1 (55) 
Leu27 rRNA quality control: putatively binds DKC1 (55) 
Ala28 rRNA quality control: putatively binds DKC1 (55) 
Glu29 rRNA quality control: binds DKC1 (55) 
Ser30 rRNA quality control: putatively binds DKC1 (55) 
Phe31 rRNA quality control: putatively binds DKC1 (55) 
Leu32 rRNA quality control: putatively binds DKC1 (55) 
Glu33 rRNA quality control: binds DKC1 (55) 
Glu34 rRNA quality control: putatively binds DKC1 (55) 
Glu35 rRNA quality control: putatively binds DKC1 (55) 
Asn85 N-glycosidic bond hydrolysis: coordination of catalytic H2O  (41) 
Gly871 Substrate binding: binds H2O2, C5-O, C5-CO, discriminates C5-CH3 (41) 
Phe89 Substrate binding: increases affinity for U:G (41) 
Gly90 Substrate binding: allows space for H2O2, C5-O, C5-CO (41,56) 
Met911 Substrate binding: binds H2O2, C5-O, C5-CO, discriminates C5-CH3 (41) 
Phe98 Substrate binding: stabilization of flipped-out U by π–π stacking (41,57) 
Asn163 Substrate binding: discriminate C4-NH2, bind N3-H and O4 (41) 
Arg220 rRNA quality control: putatively binds DKC1 (55) 
Ala221 rRNA quality control: putatively binds DKC1 (55) 
Arg222 rRNA quality control: putatively binds DKC1 (55) 
Arg223 rRNA quality control: putatively binds DKC1 (55) 
Ala224 rRNA quality control: putatively binds DKC1 (55) 
Leu225 rRNA quality control: putatively binds DKC1 (55) 
Ala226 rRNA quality control: putatively binds DKC1 (55) 
Gly227 rRNA quality control: putatively binds DKC1 (55) 
Leu228 rRNA quality control: putatively binds DKC1 (55) 
Met229 rRNA quality control: putatively binds DKC1 (55) 
Pro230 rRNA quality control: putatively binds DKC1 (55) 
Glu231 rRNA quality control: binds DKC1 (55) 
Val232 rRNA quality control: putatively binds DKC1 (55) 
Gln233 rRNA quality control: putatively binds DKC1 (55) 
His239 N-glycosidic bond hydrolysis: binds O
2, stabilization of transition state 
– charge 
(41,57) 
Pro240 Intercalating loop Excision-DNA incision (41,56) 
Ser241 Excision-DNA incision (41) 
Pro242 Excision-DNA incision (41) 
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Aim of the project 
hSMUG1 is the most important back-up enzyme for hUNG, the latter being the major UDG in 
human cells as well as having a crucial function in immunoglobulin gene diversification in 
activated B cells where cytosine in R-loop structures is deaminated. However, the (back-up) 
role for hSMUG1 in immune function is elusive. Thus, the aim of the present investigation was 
to determine hSMUG1 excision activity for uracil in R-loop DNA. This activity was compared 
to that in bubble U-DNA, another important structure formed transiently in cells during cellular 
processes as e.g. DNA replication.  
Because hSMUG1 was found to exhibit uracil excision activity in both bubble and R-loop DNA, 
the next aim of the project was to produce purified hSMUG1 mutant protein to investigate 
whether certain amino acid replacements may interfere with enzyme function towards these U-
DNA substrates. After purifying hSMUG1 S26R/E35D protein to apparent physical homoge-
neity, it was investigated for excision activity for uracil in bubble and R-loop DNA together 
with hSMUG1 P240G protein that was purified by another member of our research group.      
Arg243 Occupies empty space after base flipping, DNA-RNA discrimination (41,57) 
Asn244 Motif 2, intercalating loop (41,56,58) 
Pro245 Motif 2, intercalating loop (41,58) 
Gln246 Motif 2, intercalating loop (41,58) 
Asn248 Motif 2, intercalating loop (41,56,58) 
Lys249 Motif 2, intercalating loop (41,58) 
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2 Materials and methods 
 
2.1 Production of recombinant hSMUG1 wild type and mutant proteins 
 
2.1.1 Production of chemically competent E. coli strains BL21(DE3)pLysS and 
Rosetta(DE3)pLysS to prepare for transformation  
 
The E. coli strain BL21(DE3)pLysS and Rosetta(DE3)pLysS are resistant to chloramphenicol 
(34 μg/ml). LB medium (3 ml) was inoculated with a single colony of the E. coli, and grown 
overnight at 37°C with vigorous shaking. On the following day, an aliquot of overnight culture 
(200 μl) was transferred to 25 ml LB medium followed by growth overnight using the same 
conditions until the culture reached an OD A600 of 0.3−0.5 (depending on the strain this takes 
2−4 h). The culture was placed on ice for 10 min and split into 4 round-bottom tubes of 6 ml 
each, which were centrifuged for 10 min at 4000 rpm at 4°C. The pellet was mixed with 3 ml 
ice cold sterile 100 mM CaCl2, left on ice for 30 min and centrifuged for 10 min at 4000 rpm a 
4°C. The resulting pellet was mixed with 400 μl ice cold sterile 100 mM CaCl2 and split into Ep-
pendorf tubes with 200 μl cells per tube.  
 
2.1.2 Transformation of E. coli strains BL21(DE3)pLysS and Rosetta(DE3)pLysS with 
plasmid pETM11-SMUG1 
An amount of 1 μl of pETM11-SMUG1 (20 ng DNA for supercoiled plasmids) was added to 
100−200 μl of competent cells and incubated for 30 min on ice, followed by incubation in a 
water bath for 45 s (BL21) or 30 s (Rosetta) at 42°C and placement on ice. Then, S.O.C. Me-
dium (ThermoFisher Scientific), 900 μl for BL21 and 500 μl for Rosetta, was added to the tube 
followed by incubation for 1 h at 37°C with shaking (225 rpm). An appropriate volume 
(100−200 μl) of the putatively transformed cells was spread on LB plate(s) containing chloram-
phenicol (34 μg/ml) and kanamycin (50 μg/ml) and grown overnight at 37°C. Bacterial colonies 
for hSMUG1 protein production were stored on the plates in the fridge at 4°C.   






2.1.3 Analysis for recombinant protein production 
 
Autoinduction 
For the un-induced sample, one colony of transformed cells was inoculated in 3 ml of MDG for 
autoinduction (ZY-5052) containing chloramphenicol (34 μg/ml) and kanamycin (50 
μg/ml). Cells were grown for at least 4 h at 37°C with shaking (300 rpm). A major fraction of 
the culture (2 ml) was withdrawn for determination of OD600, which needs to be in the range 
0.4−0.6. When reaching the desired OD600, the volume of the culture (Vculture) to be used is given 
by the formula: Vculture (μl) = OD600/0.8 × 1000. Then, the culture was transferred to a 1.5-ml 
Eppendorf tube and centrifuged for 1 min at 13 000 rpm, followed by removal of the superna-
tant. The cell pellet was stored at −20°C. For the induced sample, shaking (300 rpm) was con-
tinued overnight at the lower temperature of 28°C. Subsequently, 200 μl of the culture was di-
luted 10-fold with 1× PBS (phosphate-buffered saline) to measure OD600. When 0.8 is divided 
by the resulting OD600, the volume of the culture (Vculture) to be used is given by the formula: 
Vculture (μl) = OD600/0.8 × 1000. For example, if 0.8/OD600 = 0.5, Vculture = 500 μl is centrifuged 
and the cell pellet stored at −20°C.  
 
Induction with isopropyl β-ᴅ-thiogalactoside 
For un-induced and induced sample, 10 colonies of transformed bacteria were transferred from 
LB plate stored at 4°C to 25 ml of LB medium containing chloramphenicol (34 μg/ml) and kan-
amycin (50 μg/ml) in an Erlenmeyer flask and grown until OD600 reached 0.4−0.6. An aliquot 
of culture (1 ml) was removed and the Vculture determined as above. The cells were harvested 
by centrifugation and the pellet stored at −20°C.  
 
For the induced sample, the culture was split into 5 tubes 3 ml each, each added 3 μl of 1 mM 
isopropyl β-ᴅ-thiogalactoside (IPTG), which were incubated for, 1) 1 h at 37°C, 2) 2 h at 37°C, 
3) 3 h at 37°C, 4) 4 h at 37°C and 5) overnight at 23°C, all with shaking (220−250 rpm). After 
each type of incubation, OD600 was measured and Vculture determined, and the cells harvested as 
above.  
 
Un-induced and IPTG-induced cells were mixed with in 100 μl of 1× Laemmli sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample buffer (Bio-Rad) and heated 
at 95°C for 10 min, followed by centrifugation at room temperature for 5 min at 13 000 rpm. 10 
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μl of all samples were analyzed at 12% TGX-SDS-PAGE gel (Bio-Rad) electrophoresed at 220 
V for 35 min. 
 
2.1.4 Gravity purification of wild type hSMUG and hSMUG S26R/E35D by large scale 
protein overproduction and affinity chromatography 
 
Large scale protein overproduction 
One colony of the Rosetta strain was transferred to 25 ml LB medium containing chloramphen-
icol (34 µg/ml) and kanamycin (50 μg/ml) followed by incubation overnight at 37°C with shak-
ing (220 rpm). All of the overnight culture was transferred to 1000 ml LB medium containing 
kanamycin (50 µg/ml) and chloramphenicol (34 µg/ml), followed by measurement of OD600 
and incubation at 37°C with shaking (220 rpm) until OD600 ≈ 0.6. Then the culture (1024 ml) 
was added 1024 μl of 1 mM IPTG (final) and incubated for 2 h at 37°C with shaking (220 rpm), 
followed by harvesting of the cells by centrifugation (6000 rpm) for 20 min at room tempera-
ture. The cell pellet was stored at −20°C for later purification. 
 
TALON affinity purification using gravity column 
After addition of 20 ml of 20 mM Tris-HCl, pH 8.0, 10 mM imidazole, 150 mM NaCl, 0.2% 
(v/v) NP-40 (tergitol), 2 mM β-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride 
(PMSF) (lysis buffer), the cell pellet was solubilized and lysozyme (final concentration, 1 
mg/ml) was added followed by incubation for 30 min at 4°C with gentle shaking. The sample 
was sonicated (30% amplitude) “10 s on, 10 s off” repeated 6 times with the beaker on ice. Then 
DNAase (final concentration, 40 μg/ml) was added, followed by incubation for 15 min at 4°C. 
The sample was transferred to SS-34 tubes and centrifuged (15 000 rpm) at 4°C for 30 min, 
followed by transfer of the supernatant (designated “crude extract”) to a fresh tube. (20 μl of 
crude extract was taken to be analyzed by SDS-PAGE later. Crude extract was added to gravity 
column with 1 ml of equilibrated TALON beads (see Appendix), and the flow-through was 
collected. The beads were washed with 5 ml of 20 mM Tris-HCl, pH 8.0, 10 mM imidazole, 
150 mM NaCl, 2 mM β-mercaptoethanol, 0.5 mM PMSF (wash 2), 5 ml of wash 3 (wash 2 
containing 1 M NaCl) and 5 ml of wash 4 (wash 2 with 20−50 mM imidazole, without PMSF). 
Protein was eluted using 4 ml elution buffer (wash 2 with 330 mM imidazole, without PMSF) 
in four fractions. The fractions were pooled followed by addition of 50 µl of AcTEV (tobacco 
etch virus) protease (Themo Fisher Scientific, Product No. 12575015), and dialyzed against 2 l 
of lysis buffer (plus fresh 2 mM β-mercaptoethanol) using the Pre-wetted RC tubing MWCO 
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16 kDa membrane (Spectra/Por, No. 132562), which should putatively remove excised His-tag. 
The dialyzed protein was transferred to equilibrated TALON beads in a gravity column fol-
lowed by incubation for 30 min at 4°C. The flow-through (i.e., protein without His-tag) was 
collected, followed by elution with 5 ml of wash 2 and 5 ml of wash 4 (to remove the rest of 
protein without His-tag). The AcTEV protease was removed from the beads with elution buffer 
(4 ml) in 4 different fractions. The protein concentration was determined by NanoDrop (Ther-
moFisher Scientific) using buffer A as blank solution. 
 
2.1.5 Purification of wild type hSMUG1 and hSMUG1 A14T/A16T by small scale 
protein overproduction and affinity purification 
 
Small scale protein overproduction  
One colony of transformed Rosetta strain bacteria was added to 3 ml LB medium containing 
chloramphenicol (34 μg/ml) and kanamycin (50 μg/ml) and incubated overnight at 37°C with 
shaking (220 rpm). Overnight culture was transferred to 50 ml LB medium in an Erlenmeyer 
flask containing the same concentration of antibiotics and incubated until OD600 reached 0.6. 
Then gene expression was induced with 50 μl of 1 mM IPTG and the culture incubated over-
night at 23°C. Bacteria were harvested by centrifugation at 3000 rpm for 20 min at room tem-
perature, followed by addition of 2 ml lysis buffer. After addition of lysozyme (final concen-
tration, 1 mg/ml), the sample was incubated with gentle shaking at 4°C for 30 min followed by 
sonication (10% amplitude) “10 s on, 10 s off” repeated 6 times with the beaker on ice. The 
sample was transferred to Eppendorf tubes and centrifuged (13 000 rpm) at 4°C for 10 min. 
Supernatant (“crude extract”) was transferred to new Eppendorf tubes (20 μl was analyzed by 
SDS-PAGE). 
 
Small scale TALON affinity purification 
Crude extract was added to 0.5 ml of equilibrated TALON beads (see Appendix) and the sus-
pension transferred to a gravity column, followed by incubation at 4°C for 30 min with gentle 
shaking. The flow-through was collected (20 μl for SDS-PAGE analysis), followed by elution 
with 5 ml of lysis buffer, and 5 ml each of wash 2−wash 4, where the eluted liquids were dis-
carded. Then elution buffer (0.5 ml) was applied to the column 3−5 times where all eluted 





2.1.6 Expression of hSMUG1 A14T/A16T, hSMUG1 S26R|E35D and hSMUG1 wild type 
by autoinduction and batch affinity purification  
 
Autoinduction 
MDG solution (20 ml) and kanamycin (50 µg/ml) were mixed in a Falcon tube, and the mixture 
was distributed to 3 tubes with 5 ml each where two of them were inoculated with one trans-
formed bacterial colony followed by incubation overnight at 37°C with shaking (220 rpm); one 
tube served as a control. On the following day, 500 μl of the overnight culture, 500 ml of ZYM-
5052 and 500 μl of kanamycin (50 μg/ml) were mixed and incubated overnight at 28°C with 
shaking (220 rpm). Bacteria were harvested by centrifugation at 6000 rpm for 20 min at 4°C. 
The cell pellet was weighted, frozen using liquid nitrogen and stored at −80°C. 
 
Batch purification with affinity TALON beads 
Bacterial pellet was added to lysis buffer (7 ml per g). After addition of lysozyme (final con-
centration, 1 mg/ml) and one EDTA-free protease inhibitor cocktail tablet (Thermo Scientific; 
lot No. VC2936735), the sample was incubated with gentle shaking at 4°C for 30 min followed 
by addition of NP-40 [tergitol; final concentration, 0.5% (v/v)], MgCl2 (final concentration, 5 
mM), DNAase (final concentration, 40 μg/ml) and RNAase (final concentration, 5 μg/ml) fol-
lowed by incubation for 20 min at 4°C and sonication (30% amplitude) for 10 min “5 s on, 4 s 
off” with the beaker on ice with steering. The sample was centrifuged (20 000 rpm) for 45 min 
at 4°C. Supernatant (“crude extract”) was placed on ice, where 20 μl was subjected to SDS-
PAGE analysis. 
 
Crude extract was mixed with 2 ml of equilibrated TALON beads (see Appendix) and the sus-
pension transferred to a 50 ml Falcon tube, followed by incubation at 4°C for 30 min with gentle 
shaking and centrifugation for 5 min at 500 × g. [The supernatant was analyzed by SDS-PAGE 
(20 μl) and thereafter discarded]. Buffer A [50 mM Tris pH 7.5, 300 mM NaCl, 10 mM imid-
azole, 2 mM βME] (10 ml) containing 10 mM imidazole was added to the beads followed by 
incubation for 5 min at 4°C with gently shaking. After centrifugation for 5 min at 500 × g, the 
supernatant was discarded (the procedure was repeated twice). 2 ml of buffer A with 100 mM 
imidazole was added, followed by incubation for 10 min at 4°C with gentle shaking and there-
after centrifugation for 5 min at 500 × g. The eluted fraction of the protein was carefully trans-
ferred to a precooled 2 ml Eppendorf tube. This final procedure was repeated twice. Fractions 
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were analyzed by SDS-PAGE at 220 V for 40 min. The fractions of the purified protein were 
pooled followed by addition of 50 μl of AcTEV protease (Themo Fisher Scientific, Product No. 
12575015), and dialyzed against 2 l of buffer A (plus 2 mM β-mercaptoethanol) using the Pre-
wetted RC tubing MWCO 16 kDa membrane (Spectra/Por, No. 132562). The protein concen-
tration was determined by NanoDrop (ThermoFisher Scientific) using buffer A as blank solu-
tion. 
 
2.2 hSMUG1 wild type and mutant proteins from other sources 
 
hSMUG1 was obtained from NEB (product No. M0336S); purified hSMUG1 wild type was 
provided by Trond Bærheim; hSMUG1 P240G protein was provided by Celine Lorentsen (59). 
 
2.3 Western blot for verification of hSMUG1 protein   
Performed SDS-PAGE for all samples used in expression test for hSMUG1. 
Trans-Blot Turbo transfer pack (Bio-Rad) for the blotting were used with 3 min transfer time 
using the blotting machine (Bio-RAd). Membrane were transferred to the clean dish. Blocking 
solution 5% (w/v) BSA in PBST (0.1 % Tween 20) was applied for 1 h at room tempera-
ture with shaking. Primary antibody; primary rabbit anti-SMUG Ab 1:2000 in 10 ml of 5% 
(w/v) BSA in PBST was used. Membrane was washed 3 × 5 min PBST (0.1% Tween 20) with 
shaking at room temperature. Then, secondary Goat anti rabbit-HRP IgG 1:2000  (Ther-
moFisher Scientific, Product No. 31460) was added together with Precision Protein M Strep 
Tactin-HRP Conjugate for 1.5 h at room temperature with shaking. Then membrane was 
washed 3 × 5 min with PBST (0.1 %) with shaking in room temperature. Membrane were placed 
on the plastic cover and was applied with Clarity Western ECL substrate for 5 min. Excess 
substrate was removed and dried by dipping edges with paper. Figure was acquired using 
the Bio-RAd ChemDoc.  
 
2.4 Base excision activity assay 
 
hSMUG1 protein was incubated with substrate (1 pmol) in a reaction mixture of 5× HEPES 
buffer (225 mM HEPES, pH 7.5, 2 mM EDTA, 10% (v/v) glycerol) 10 mg/ml BSA, 1 mM 
DTT, and 1 M KCl. The reaction was terminated by the addition of (Stop solution) 20 mM 
EDTA, 0.5% (w/v) SDS, and 10 µg proteinase K, incubated for 10 min at 37°C. The DNA was 
ethanol precipitated by the addition of 16 µg transfer RNA (tRNA) and 0.1 M sodium acetate 
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at –20°C overnight. The DNA pellets were collected by centrifugation (13000 rpm, 4°C for 30 
min) and washed in 70% ethanol (–20°C). Then, dried pellets were mixed with in 10 µl of 0.1 
M NaOH and was heated at 90°C for 10 min. Before loading into the denaturing PAGE, the 
samples were mixed with formamide gel loading buffer [80% (v/v) formamide, 1 mM EDTA 
and 1% (w/v) blue dextran]. Samples (10 µl) were prepared for electrophoresis by the addition 
of 10 µl of the loading buffer. A volume of 5 µl was subjected to denaturing PAGE [20% (w/v) 
polyacrylamide gel with 3% (v/v) formamide] at 200 V for 1.5 h. Visualization and quantifica-
tion were performed by fluorescence imaging analysis using ImageQuant Software (Molecular 
Dynamics Inc.). Figures was acquired using Typhoon TrioTM (GE Healthcare). The graphs were 
drawn using KaleidaGraph version 4.1.0 (Synergy Software). 
 
2.5. Substrate hybridization 
 
The only practical way of detecting specific nucleic acid sequences in a complex nucleic acid 
mixture is to use labeled probes in a hybridization reaction. In this case, Cy3-54Ucenterbub-
ble18, 18RNAfor54comp and 18RNAfor54comp was used. DNA Substrate was hybridized by 
mixing, 1 µl Cy3-54Ucenterbubble18 (100 pmol/µl), 2 µl complementary strand (54bub-
ble18comp, 100 pmol/µl), and 7 µl 1× STE buffer containing 10 mM Tris-HCl, pH 8.0, 50 mM 
NaCl and 1 mM EDTA. For R-loop, the mixture was the same as mentioned above but with the 
addition of 2 µl of 18RNAfor54comp and 5 µl of STE buffer. The mixture was incubated at 
95°C, 3 min in the thermocycler (Bio-Rad) and was right after added with 90 µl of 1× TE buffer 
(10 mM Tris-HCl, pH 7.5 and 1 mM EDTA, pH 8.0). Hybridization was verified using the na-
tive PAGE with TBE by preparing a mixture of 9 µl of water and 1 µl of 10 pmol/µl substrate 
with 10 µl of non-denaturing loading buffer. 5 µl was subjected for SDS-PAGE at 150 V for 2 













3.1 Production of recombinant hSMUG1 wild type and mutant proteins 
 
To initiate hSMUG1 production, the E. coli strain BL21 Rosetta was used to overexpress a full-
length version of the human SMUG1 gene inserted into the plasmid pETM11. As shown in 
Figures 7–9, gene expression was induced with 1 mM isopropyl β-ᴅ-thiogalactoside (IPTG) 
following incubation for, 1) 1 h at 37°C, 2) 2 h at 37°C, 3) 3 h at 37°C, 4) 4 h at 37°C and 5) 
overnight at 23°C. The results presented in Figures 7A, 8A and 9A show that the optimal incu-
bation period was overnight at 23°C, which was consequently applied in further experiments. 
«Small scale protein overproduction» and «Large scale gravity purification» (see «Materials 
and Methods») was used (Figure 7B and 9B) in the purifications described below.    
 
3.1.1 Wild type hSMUG1 
 
The E. coli strain Rosetta(DE3)pLysS was transformed with the plasmid pETM11-SMUG1 
where the SMUG1 gene was induced with IPTG (Figure 7A). hSMUG1 was produced by 
«Small scale protein overproduction», where crude extract was subjected to a gravity column 
containing TALON beads attached with Co2+ resin (see “Materials and methods”) able to bind 
the His-tagged hSMUG1 protein. After protein elution and removal of the His-tag by the 
AcTEV protease, the purified fractions were analyzed by SDS-PAGE, showing one single band 
with the expected MW of hSMUG1 protein, which indicates apparent physical homogeneity 
(Figure 7B). In addition, the identity of the protein was confirmed by Western blotting showing 
reaction with anti-SMUG1 antibody (Figure 7C and 9C). Because our aim was to analyze 
hSMUG1 activity for uracil in bubble-structured DNA, the purified fractions were tested using 
bubble U-DNA as substrate (see Figure 11B). Unfortunately, our purified hSMUG1 [designated 
hSMUG1(CAR)]did not show any activity for bubble U-DNA (Figure 7D, lanes 5 and 6), as 
compared to the commercially available hSMUG1 preparation provided by New England Bio-
chemicals [hSMUG1(NEB)], which caused significant uracil excision (Figure 7, lanes 9 and 
10). This contrasts with control incubations without enzyme showing no cleaved substrate (Fig-
ure 7D, lane 2). Thus, the presented purification were unsuccessful in producing an active uracil 
excising enzyme. This is a general challenge regarding the hSMUG1 protein. Interestingly, 
however, is the observation that hSMUG1(NEB), similar to the control incubation without en-
zyme (Figure 7D, lane 1), did not show any U-DNA incision activity for uracil in bubble U-
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DNA (Figure 7D, lanes 7 and 8). This contrasts with the significant incision activity of 
hSMUG1 at uracil in dsDNA and ssDNA (42).       
 
3.1.2 hSMUG1 A14T/A16T 
 
Using a similar protocol as for hSMUG1(CAR), but this time with the plasmid pETM11-
SMUG1 A14T/A16T expressing a mutated version of the SMUG1 gene, pure hSMUG1 
A14T/A16T mutant protein was attempted to be produced. The rationale was to investigate 
whether replacing Ala14 and Ala16, which is believed to participate in RNA binding or func-
tion, might influence hSMUG1 activity (Table 1). As before, protein production was optimal 
by incubating the bacteria overnight at 23°C (Figure 8A). Although in vivo overproduction of 
the hSMUG1 A14T/A16T protein was clearly detectable (Figure 8A) and crude cell extract was 
subjected to «Small scale protein overproduction», unfortunately, no purified protein bands 
were detectable in the SDS-PAGE gel (Figure 8B).  
 
3.1.3 hSMUG1 S26R/E35D 
 
Because Ser26 and Glu35 (Table 1) have been demonstrated to be involved in rRNA quality 
control by putatively binding DKC1 (55), it is important to investigate whether replacement of 
these amino acids also affects hSMUG1 activity. Consequently, the plasmid pETM11-SMUG1 
S26R/E35D expressing such a double mutated version of the SMUG1 gene was used to over-
produce the corresponding hSMUG1 mutated protein by a similar protocol as before, where the 
in vivo protein production was optimal by incubating the bacteria overnight at 23°C (Figure 
9A). However, this time crude extract was subjected to the «Large scale gravity purification» 
protocol. After protein elution from the TALON beads and removal of the His-tag by the 
AcTEV protease, the purified fractions were analyzed by SDS-PAGE, showing one single band 
with the expected MW of the hSMUG1 protein (Figure 9B), indicating apparent physical ho-
mogeneity. The identity of the hSMUG1 S26R/E35D protein was further confirmed by Western 






Figure 7. Production of recombinant hSMUG1 protein. (A) The pETM-11 vector. (B) Overproduc-
tion of wild type hSMUG1 protein in E. coli Rosetta(DE3)pLysS transformed with plasmid pETM11-
SMUG1. (C) SDS-PAGE analysis of different fractions obtained during «Small scale protein overpro-
duction» of hSMUG1, using gravity column containing TALON beads attached with Co2+ resin. Protein 
was eluted with 20 mM Tris-HCl, pH 8.0, 330 mM imidazole, 150 mM NaCl, 2 mM β-mercaptoethanol, 
0.5 mM PMSF (elution buffer). Purified protein was collected in two fractions (last two lanes to the 
right; protein concentration of 0.085 mg/ml for the pooled fractions). (D) Western blot of the purified 
protein fractions using primary rabbit monoclonal anti-SMUG1 antibody and secondary (horseradish 
peroxidase conjugated) goat anti rabbit-HRP IgG, showing verification of the presence of hSMUG1 in 
different dilutions. (E) Test for enzyme activity of hSMUG1(NEB) and purified protein 
[hSMUG1(CAR)] with bubble U-DNA. Lanes 1 and 2, no enzyme; lanes 3 and 4, test for U-DNA inci-
sion activity of hSMUG1(CAR); lanes 5 and 6, test for uracil excision activity of hSMUG1(CAR); lanes 
7 and 8, test for U-DNA incision activity of hSMUG1(NEB); lanes 9 and 10, uracil excision activity of 
hSMUG1(NEB). Since there was neither activity for U-DNA incision nor uracil excision exhibited by 
hSMUG1(CAR), our enzyme was clearly inactive. This contrasts with hSMUG1(NEB), which dis-








Figure 8. Production of recombinant hSMUG1 A14T/A16T protein. (A) Overproduction of 
hSMUG1 A14T/A16T protein in E. coli Rosetta(DE3)pLysS transformed with plasmid pETM11-
SMUG1 A14T/A16T. (B) SDS-PAGE of different fractions obtained during «Small scale protein over-
production» of hSMUG1 A14TA16T. Unfortunately, no bands of the expected MW of hSMUG1 was 
observed in the gel (lanes 4 and 5) indicating that the purification was unsuccessful. See Figure 7 and 
“Materials and methods” for experimental details. 
   
3.2 hSMUG1 excises uracil in bubble and R-loop DNA 
 
An oligodeoxyribonucleotide with the damaged base residue (in this case, uracil) inserted at a 
specific position is used in a common method to evaluate DNA glycosylase activity (Figure 
11A). Enzymatic excision of uracil results in an alkali-labile AP site, which can be monitored 
by the extent that e.g. NaOH cleaves such sites by β/δ-elimination reaction, where cleaved DNA 
is separated from un-cleaved DNA by PAGE under denaturing conditions (Figure 11B). Such 
substrate was incubated with increasing amounts of hSMUG1, which was fluorescently labeled 
at the 5´ end of the damaged strand (Figure 11A). 
 
3.2.1 Bubble and R-loop DNA substrates were efficiently prepared 
 
The hybridization reaction is a sequence-specific interaction of two complementary single-
stranded nucleic acids that results in the production of partial or complete double-stranded nu-
cleic acid molecules. Bubble U-DNA was made by hybridizing a 5´ fluorescently labeled strand 
of 54 nucleotides (nt) with a partially complementary strand (also of 54 nt), where the 18-nt 
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central (i.e. the bubble) region of the former lacked proper complementarity to the latter. The 
R-loop U-DNA is identical to this bubble DNA, but contains an additional 18-nt RNA strand 
that is complementary to the “bubble region” of the unlabeled DNA strand (Figure 11A). Fol-
lowing the hybridization procedure (see Materials and Methods), the integrity and purity of the 
bubble and R-loop U-DNA substrates produced was verified by native PAGE. Consequently, 
the bubble U-DNA preparation showed no presence of un-hybridized labeled strand indicating 
that the two DNA oligonucleotides were successfully hybridized to produce the substrate (Fig-
ure 10). Likewise, the R-loop U-DNA preparation showed no presence of un-hybridized labeled 
strand or bubble U-DNA, indicating that the three oligonucleotides were successfully hybrid-
ized to produce the substrate  (Figure 10). Therefore, in each case, the Cy3-labeled DNA strand 




Figure 9. Production of recombinant hSMUG1 S26R/E35D protein. (A) Overproduction of 
hSMUG1 S26R/E35D protein in E. coli Rosetta(DE3)pLysS transformed with plasmid pETM11-
SMUG1 S26R/E35D. (B) SDS-PAGE of different fractions obtained during «Large scale gravity puri-
fication» of hSMUG1 S26R/E35D using gravity column containing TALON beads attached with Co2+ 
resin. The eluted mutant protein fractions were pooled (final concentration, 0.12 mg/ml). (C) Western 
blot of the purified protein using anti-SMUG1 antibody verified the identity of hSMUG1 S26R/E35D. 










Figure 10. Verification of bubble and R-loop U-DNA integrity by native PAGE. The native PAGE 
gel was equilibrated and run with TBE buffer. DNA substrate (1 pmol) was loaded on the gel in a volume 
of 5 µl of non-denaturing loading buffer [10 mM Tris-HCl, pH 7.6, 60% (v/v) glycerol, 60 mM EDTA, 
1% (w/v) blue dextran] and run at 150 V for 2 h. 
 
3.2.2 hSMUG1 excises uracil from DNA bubble more efficient than from R-loop 
 
The lack of knowledge on hSMUG1 activity for damaged bases in bubble and R-loop DNA 
prompted us to investigate hSMUG1 excision activity for uracil in these structures. In addition 
to the commercially available hSMUG1(NEB), another full-length enzyme was produced in 
our research group [hSMUG1(TB) (60)] and analyzed together with the former. 
 
We observed that hSMUG1(NEB) exhibited significant activity for uracil in bubble and R-loop 
DNA (Figure 11C, upper and lower panels, respectively), increasing as a function of protein 
concentration (Figure 11D). Interestingly, the activity for bubble U-DNA was significantly 
higher than for R-loop U-DNA. The same was observed with hSMUG1(TB) (Figure 11E), 
which, however, demonstrated significantly lower activity (Figure 11F). This is probably due 
to protein inactivation during purification and handling, an issue which we routinely observed 
making preparation of active hSMUG1 challenging.  
 
3.3 hSMUG1 S26R/E35D excises uracil from R-loop DNA similarly or 
slightly more efficient than from DNA bubble 
 
Apparently physical homogeneous preparation of hSMUG1 S26R/E35D protein (Figure 9B) 
was exposed to uracil in bubble and R-loop DNA. As expected, this mutant protein, in which 
amino acid residues involved in RNA metabolism were replaced (55), demonstrated significant 
uracil-excising activity in both substrates (Figure 11A). However, quite interesting and unex-
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pected, the protein dependent increase in hSMUG1 S26R/E35D activity exhibited altered pref-
erence for uracil in bubble and R-loop DNA. Thus, while wild type hSMUG1 excised uracil in 
DNA bubble more efficient than in R-loop (Figure 11D and F), hSMUG1 S26R/E35D protein 
excised uracil in R-loop DNA similarly or slightly more efficient than in DNA bubble (Figure 




Figure 11. hSMUG1 excises uracil in DNA bubble and R-loop. (A) Bubble U-DNA substrate hybrid-
ized with RNA forms R-loop U-DNA substrate. (B) The base excision assay used. (C–F) Protein de-
pendence of uracil excision from bubble (violet) and R-loop DNA (light blue). hSMUG1(NEB) (C and 
D) or hSMUG1(TB) (E and F) was incubated with either bubble U- DNA (C and E, upper panels) or R-
loop U-DNA (C and E, lower panels) in 45 mM HEPES [4-(2-hydroxyethyl)-1-piperazineethane-sul-
fonic acid], pH 7.5, 0.4 mM EDTA, 1 mM DTT, 70 mM KCl, 2% (v/v) glycerol, 0.1 mg/ml BSA (reac-
tion buffer) at 37°C for 20 min. Excision product was separated from un-excised DNA by PAGE at 200 
V for 1.5 h using a 20% (w/v) gel with 3% (v/v) formamide. Each value in D and F represents the 
average (± SD) of 8–19 independent measurements. Abbreviation: nt, nucleotides. 
 
 
3.4 hSMUG1 P240G excises uracil from R-loop DNA more efficient than 
from DNA bubbles  
 
Because Pro240 is part of the His239–Lys249 intercalating loop in hSMUG1 (Table 1), which 
acts as a “wedge” and is inserted into the DNA double helix in the region of a damaged nucle-
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otide (56), replacement of this amino acid might affect hSMUG1 activity including the sub-
strates investigated in this report. Consequently, an apparently physical homogeneous prepara-
tion of hSMUG1 P240G protein produced in our research group (59) was exposed to uracil in 
bubble and R-loop DNA. As a result, this mutant protein demonstrated significant uracil-excis-
ing activity in both substrates (Figure 14A) increasing as a function of protein concentration 
(Figure 14B). Interestingly, hSMUG1 P240G exhibited altered preference for uracil in bubble 
and R-loop DNA. Thus, while wild type hSMUG1 excised uracil in DNA bubble more efficient 
than in R-loop (Figure 11D and F), this was completely reversed regarding the hSMUG1 P240G 
mutant protein (Figure 14B). 
 
 
Figure 12. hSMUG1 S26R/E35D activity for excision of uracil in bubble and R-loop DNA (A) 
hSMUG1 S26R/E35D was incubated with bubble U-DNA (left panel) or R-loop U-DNA (right panel) 
as described in Figure 11. (B) Protein dependence of uracil excision from bubble (violet) and R-loop 
DNA (light blue). Each value represents the average (± SD) of 4–6 independent measurements. Abbre-
viation: nt, nucleotides. 
 
 
3.5 Kinetic analysis of hSMUG1 wild type and mutant proteins for excision 
of uracil from bubble and R-loop DNA  
 
The kinetic analysis is based on a model for hSMUG1 presented previously (42), considering 
that hSMUG1 obeys saturation kinetics regarding enzyme concentration at a certain substrate 
concentration. Specifically, we used [S]0 = 50 nM in all our experiments, while [E]0 was in-
creased depending on the activity of the hSMUG1 preparation investigated. In each case, Vmax 
(nM/min) and KD (nM) were determined if the velocity (v) approaches saturating conditions. In 
several cases, the enzyme did not appear active enough to provide v values beyond the initial 
linear range, which prevents determination of Vmax and KD. Kinetic parameters were determined 































Based on the experiments with hSMUG1(NEB) exposed to bubble U-DNA, we made one “v 
versus [E]0” graph from the average (± SD) values (Figure 14A), and another graph from all 
determined values (Figure 14B). Both graphs show that the enzyme excellently obeys saturation 
kinetics, giving a KD of 2.5 ± 0.3 nM/Vmax of 3.0 ± 0.1 nM/min (average values), and a KD of 
2.4 ± 0.1 nM/Vmax of 2.99 ± 0.04 nM/min (all values) for uracil excision, resulting in a Vmax/KD 
of 1.2 min-1 (Table 2). Based on the experiments with hSMUG1(NEB) exposed to R-loop U-
DNA, we made corresponding graphs from the average (± SD) (Figure 14A) and all determined 
values (Figure 14C). They also show that the enzyme excellently obeys saturation kinetics, 
giving a KD of 6 ± 2 nM/Vmax of 1.6 ± 0.2 nM/min (average values), and a KD of 5.5 ± 0.6 
nM/Vmax of 1.58 ± 0.07 nM/min (all values) for uracil excision, resulting in a Vmax/KD of ~0.28 
min-1 (Table 2). In conclusion, the Vmax/KD values show that hSMUG1 is about 4 times more 
efficient in excising uracil in bubble than in R-loop DNA, as reflected in both a higher Vmax and 




Figure 13. hSMUG1 P240G activity for excision of uracil in bubble and R-loop DNA. (A) hSMUG1 
P240G was incubated with bubble U-DNA (left panel) or R-loop U-DNA (right panel) as described in 
Figure 11. (B) Protein dependence of uracil excision from bubble (violet) and R-loop DNA (light blue). 




Unfortunately, the experiments with hSMUG1(TB) purified in our research group (60) resulted 
in linear “v versus [E]0” graphs for both bubble (Figure 14D and E)  and R-loop U-DNA (Figure 
14D and F), excluding determination of KD and Vmax. The experiments with the hSMUG1 

































Figure 14. hSMUG1 kinetics for excision of uracil in bubble and R-loop DNA. (A–F) Uracil exci-
sion rate v as a function of enzyme concentration [E]0 at an initial U-DNA concentration [S]0 of 50 nM. 
The graphs for hSMUG1(NEB) obey saturation kinetics excellently for bubble DNA (A, R value of 
0.99703; B, R value of 0.9929) as well as R-loop DNA (A, R value of 0.98798; C, R value of 0.97678), 
which resulted in the kinetic parameters presented in Table 2. This contrasts with the analysis of 
hSMUG1(TB) which only resulted in linear graphs excluding determination of KD and Vmax (D–F).  
 
Fortunately, the experiments with the hSMUG1 P240G mutant protein purified in our research 
group (59) and exposed to R-loop U-DNA resulted in “v versus [E]0” graphs from the average 
(± SD) (Figure 16A) and all determined values (Figure 16C) showing that the enzyme excel-
lently obeys saturation kinetics, giving a KD of 60 ± 10 nM/Vmax of 3.1 ± 0.3 nM/min (average 
values), and a KD of 62 ± 9 nM/Vmax of 3.2 ± 0.3 nM/min (all values) for uracil excision (Table 
2). However, the graphs for hSMUG1 P240G exposed to bubble U-DNA resulted in linear 







Figure 15. hSMUG1 S26R/E35D kinetics for excision of uracil in bubble and R-loop DNA. (A–C) 
Uracil excision rate v as a function of enzyme concentration [E]0 at an initial U-DNA concentration [S]0 
of 50 nM. The graphs for hSMUG1 S26R/E35D resulted in linear graphs only, excluding determination 
of KD and Vmax. However, this mutant protein exhibits a marginally, although significant, higher activity 





Figure 16. hSMUG1 P240G kinetics for excision of uracil in bubble and R-loop DNA. (A–C) Uracil 
excision rate v as a function of enzyme concentration [E]0 at an initial U-DNA concentration [S]0 of 50 
nM. The graphs for hSMUG1 P240G using bubble DNA resulted in linear graphs only, excluding de-
termination of KD and Vmax. The graphs for hSMUG1 P240G obey saturation kinetics excellently for R-
loop DNA (A, R value of 0.99388; C, R value of 0.95531), which resulted in the kinetic parameters 




Table 2. Kinetic parameters for hSMUG1(NEB) and hSMUG1 P240G in bubble and R-
loop DNA 
Parameter Substrate (50 nM) 
 bubble U-DNA R-loop U-DNA 






2.5 ± 0.3 
3.0 ± 0.1 
1.2 
 
2.4 ± 0.1 
2.99 ± 0.04 
1.2 
 
6 ± 2 
1.6 ± 0.2 
0.27 
 
5.5 ± 0.6 













60 ± 10 
3.1 ± 0.3 
0.052 
 
62 ± 9 
3.2 ± 0.3 
0.052 
1, determined from a graph showing the average values of v at each [E]0; 2, determined from a graph 



























During immunoglobulin gene diversification in activated B cells, targeted deamination by AID 
followed by hUNG engagement is important for CSR and SHM by providing DNA double 
strand breaks and mutagenesis (4), respectively. It has been reported that hSMUG1 may sub-
stitute for hUNG in CSR under certain conditions (27,45), although its role in immune function 
is largely unclear. The present results demonstrate that hSMUG1 excises uracil from a DNA 
bubble structure significantly more efficient than from a homologous R-loop structure (Figure 
14A and D). This accords with the belief that the enzyme does not execute an important function 
in immunoglobulin gene diversification and maybe during transcription. It rather supports the 
role of hSMUG1 as a back-up UDG for hUNG (38), since transiently bubble structures arise 
during several processes in the genome. To our knowledge, this is the first report describing 
hSMUG1 activity for uracil in bubble and R-loop DNA. Importantly, another member of our 
research group analyzed hUNG using the same substrates (61), and comparing the hUNG re-
sults with that of hSMUG1 strongly support this conclusion. First, hUNG exhibits a similar 
level of uracil excision in bubble DNA at a five times lower concentration than hSMUG1 (Fig-
ure 17A), although the latter has a 4.4-times higher efficiency as indicated by Vmax/KD in bubble 
than R-loop DNA (Figure 17B and Table 3). Second, however, we observe the striking result 
that that hUNG only needs a two order of magnitude lower concentration to excise uracil in R-
loop DNA similarly efficient as hSMUG1 (Figure 17A), where Vmax/KD shows a nearly three 
order of magnitude higher efficiency than hSMUG1 (Table 3). To largely exclude possible bias 
due to hSMUG1 inactivation, which lowers the Vmax value, the KD of hUNG is 20 times lower 
(reflecting 20 times higher affinity) for uracil in R-loop than in bubble DNA. This is very dif-
ferent from the KD of hSMUG1, which is about twice higher for uracil in bubble than in R-loop 
DNA. In conclusion, the KD of hUNG is 500 times lower for uracil in R-loop DNA than that of 
hSMUG1 (Table 3), suggesting that hSMUG1 hardly has any important role in immunoglobulin 
gene diversification or in DNA repair during transcription in general, although it may function 







Table 3. Kinetic parameters of hUNG and hSMUG1 for U-DNA (50 mM) 
Parameter Substrate (50 nM) 






0.25 ± 0.06 
3.4 ± 0.5 
14 
 
0.012 ± 0.003 







2.5 ± 0.3 
3.0 ± 0.1 
1.2 
 
6 ± 2 
1.6 ± 0.2 
0.27 
The parameters were calculated from the average values (±SD) using 0.0125–0.25 nM hUNG and 0.15–
15 nM hSMUG1. 
hSMUG1 is also believed to function in rRNA quality control which includes the telomerase 
RNA component (hTERC), by e.g. regulating the presence of base modifications. Thus, 
hSMUG1 binds dyskerin (DKC1), the major pseudouridine synthase in mammals, where the 
Ser26 and Glu35 residues is participating (55). However, these amino acids have not been sus-
pected to be involved in the DNA glycosylase catalytic function (Table 1). Interestingly, 
the results show that the hSMUG1 S26R/E35D mutant protein excised uracil in R-loop DNA 
similarly or slightly more efficient than in DNA bubble, i.e., close to the opposite of wild type 
hSMUG1, suggesting that replacement of these amino acids alters enzyme function (Figures 
13B and 16A). This feature was even more pronounced with the hSMUG1 P240G mutant pro-
tein (Figures 14B and 17A), even though Pro240 is part of the His239–Lys249 intercalating 
loop in hSMUG1, which acts as a “wedge” and is inserted into the DNA double helix in the 
region of a damaged nucleotide (56). However, the putative role of the intercalating loop in 
bubble and R-loop U-DNA is unknown. Thus, while wild type hSMUG1 excised uracil in DNA 
bubble significantly more efficient than in R-loop, this was completely reversed regarding the 
hSMUG1 P240G mutant protein, indicating a role of Pro240 in stabilizing the hSMUG1–bubble 




Figure 17. Uracil excision activity of hUNG and hSMUG1 in bubble and R-loop DNA. (A) Protein 
dependence of uracil excision from bubble (violet) and R-loop DNA (light blue). Each value represents 
the average (± SD) of 4–9 (hUNG) (61) and 9–19 (hSMUG1) independent measurements. (B)   Uracil 
excision rate v as a function of enzyme concentration [E]0 at an initial U-DNA concentration [S]0 of 50 
nM. The graphs for obey saturation kinetics where determined values of KD and Vmax are presented in 
Table 3. 
 
Although the hSMUG1(TB), hSMUG1 S26R/E35D and hSMUG1 P240G proteins were pro-
duced by the same protocol, it is principally unreliable to compare their precise enzyme activity 
levels because of extensive hSMUG1 protein inactivation during production and storage. How-
ever, because their activities were determined at the same or similar time for all substrates using 
the same amount of enzyme, it should be safe to compare how effective each preparation is 
towards the different four substrates tested in our research group, where the data is presented 
for each substrate (Figure 18, A–D) as well as for each enzyme preparation (Figure 18, E–H), 
where the kinetic parameters for ssU-DNA and hmU-ssDNA is presented in Table 4. The results 
show that wild type hSMUG1 exhibits the highest catalytic efficiency for ssU-DNA (Vmax/KD 
11–12 min-1), followed by hmU-ssDNA (Vmax/KD ~3 min
-1) (Table 4) ≈ bubbleU-DNA (Vmax/KD, 
1.2 min-1) and then R-loopU-DNA (Vmax/KD ~0.27–0.29 min
-1) (Table 2). The mutated 
hSMUG1 proteins S26R/E35D and P240G exhibit no significant activity for hmU-ssDNA, 
while that for the uracil substrates is easily detectable. Thus, replacing S26 and E35, or P240, 
with another amino acid residue severely obstruct hSMUG1 activity for hmU as opposed to U 
in DNA. The velocity v for hSMUG1 S26R/E35D is highest for uracil in ssDNA followed by 
R-loop and bubble DNA (Figure 18G), while for hSMUG1 P240 v decreases for U in bubble 
DNA (Figure 18G) much more than in ssDNA (Vmax/KD, 0.1–0.2 min
-1, Table 4) with R-loop 
in between (Vmax/KD, 0.052 min
-1) (Table 2). The ten and 100–200 times higher KD for uracil 
excision in R-loop (Table 2) and single-stranded DNA (Table 4) exhibited by wild type 
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hSMUG1 and hSMUG1 P240, respectively, shows that replacing Pro with Gly seems to ob-
struct binding to the substrate, which is especially pronounced for ssDNA. This may reflect 
more (unspecific) binding options for the enzyme in the more complex R-loop substrate com-
pared to ssU-DNA. Because Pro240 is part of the His239–Lys249 intercalating loop in 
hSMUG1 (56) (Table 1) and is thus close to the catalytic function, it was not so surprising that 
replacing it with Gly obstructed the enzyme activity for hmU in ssDNA (Figure 18D). This 
contrasts with the interesting result that replacing Ser26 and Glu35 (Table 1), which is involved 
in rRNA quality control by putatively binding DKC1 (55), demonstrated devastating obstruc-
tion of activity for hmU in ssDNA (Figure 18D). Because crystal structure of hSMUG1 together 
with substrate or substrate analogs has not yet been obtained, computer-assisted molecular mod-
eling of hmU-ssDNA bound to hSMUG1 with Ser26 and/or Glu35 replaced might contribute 
to a clarification.           
 
Figure 18. Comparison of hSMUG1 wild type, hSMUG1 S26R/E35D and hSMUG1 P240G base 
excision kinetics for ssU-DNA, bubble U-DNA, R-loop U-DNA and hmU-ssDNA. (A–D) Velocity 
(v) as a function of enzyme concentration [E]0 for each substrate is compared. (E–H) v as a function of 
[E]0 for each hSMUG1 preparation is compared. The original experiments using bubble and R-loop U-
DNA (violet and light blue, respectively) is presented in this thesis, those using ssU-DNA (blue) in the 




Table 4. Kinetic parameters for wild type hSMUG1(NEB, TB) and hSMUG1 P240G in 
ssU-DNA and hmU-ssDNA 
Parameter Substrate (50 nM) 
 ssU-DNA hmU-ssDNA 






0.28 ± 0.07 
3.1 ± 0.3 
11 
 
0.25 ± 0.03 
3.0 ± 0.1 
12 
 
0.8 ± 0.1 
2.20 ± 0.08 
2.8 
 
0.77 ± 0.06 















30 ± 20 
1.3 ± 0.3 
 
 
30 ± 30 





40 ± 50 
2 ± 2 
 
40 ± 20 
2.4 ± 0.6 
 
 nd  
 nd  
 
 nd  






40 ± 20 
4.0 ± 0.9 
 
 
41 ± 9 
4.2 ± 0.5 
0.1 
 
   
 0  
 
   






17 ± 3 
3.0 ± 0.2 
0.18 
 
18 ± 3 
3.1 ± 0.2 
0.17 
 
   
 0  
 
   
 0  
c, enzyme preparations compared/measured at similar time; f, the most fresh enzyme preparation tested; 
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Equilibration of TALON beads for batch purification 
 
Equilibration of beads include removal of storage buffer (20% ethanol), washing with Milli-Q 
water and then with buffer A (50 mM Tris-HCl, pH 7.5, 300 mM NaCl and 2 mM β-mercap-
toethanol). The beads were collected by centrifugation at 500 × g for 5 min, where supernatant 
was discarded. 10× of beads volume of Milli-Q water were added followed by centrifugation 
again at 500 × g for 5 min. Buffer A (10 ml) was added followed by incubation for 10 min at 
4°C and centrifugation for 5 min at 500 × g. Supernatant was discarded and the procedure was 
repeated twice. Buffer A (10 ml) with 10 mM imidazole was added followed by incubation for 
5 min at 4°C and centrifugation for 5 min at 500 × g and removal of buffer.  
 
Equilibration of TALON beads for large scale gravity purification 
 
1 ml TALON beads were equilibrated using 4 ml Milli-Q water (Merck) and wash 2 (20 mM 
Tris-HCl, pH 8.0, 10 mM imidazole, 150 mM NaCl, 2 mM β-mercaptoethanol (add fresh) and 
1 μl PMSF buffers (2 × 4 ml). 
 
Equilibration of TALON beads for small scale gravity purification  
 
Took 0.5 ml TALON beads, wash with 5 ml water and 2 times 5 ml wash 2 (20 mM Tris 8.0   





Protocol 2: Base excision assay 
 
Vials was kept on ice and in darkness during the assay. 
 
Reaction Mixtures:  
  




HEPES buffer + DTT 5× 1× 4 8 
KCl 1 M 70 mM 1.4 2.8 
BSA 10 mg/ml 5× 1 2 
Labelled oligo 1 pmol/μl 1 pmol 1 2 










1. Take 199 μl of 5× HEPES buffer/Tris-HCl and add 1 μl of freshly made 1 M DTT prior 
to the experiment.   
2. Mix the reaction and add enzyme at last   
3. Spin down 4000 rpm for 1 min at RT.  
4. In at 37°C for 20 min.   
5. Put on ice. Spin down, terminate the reaction with 45 μl of stop solution and 1 μl 
of Protenase K (10 mg/ml), mix up and down by the pipet, incubate at 37°C for 10 min. 
Spin down and put on ice.  
6. Cold down 96% ethanol/0.1 M NaAc in the freezer.  Add 150 ml 96% ethanol/0.1 
M NaAc to each tube and then + 1.6 μl tRNA (16 mg from Stock: 10 mg/ml) per sam-
ple. Invert the tubes several times.   
7. Incubate the tubes at –70°C for 2 h, or overnight at –20°C in darkness.   
8. Centrifuge the tubes at 13 000 rpm, 15 min two times with different position of the tubes 
at 4°C. Remove the supernatant.  
9. Add 300 ml cold 70% ethanol (freezer).  
10. Centrifuge at 13 000 rpm, 5 min at 4°C. Remove the supernatant.  
11. Centrifuge at 13 000 rpm, 1 min at 4°C. Remove the rest of the supernatant with the 
pipette.  
12. Dry the pellet for 1–20 min on ice at in the hood. Check that ethanol is completely evap-
orated.   
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13. Dissolve pellet in 10 ml 0.1 M NaOH (heat for 10 min at 90°C).  
14. Mix with 10 μl of denaturing loading buffer prior the gel run (when gels are ready and, 
in the chamber), mix with up and down pipetting and load to the wells of gel.  
15. Fill the gel chamber with running buffer and carefully remove the comb. Wash the gel 
wells carefully using the 1000 ml pipette to remove the residual gel particles. This part 
is very critical in making the DNA bands sharper and straight.  
16. Load 5 μl of loading solution with sample DNA into the wells carefully and run the gels 






Protocol 3: Hybridization of bubble U-DNA and R-loop U-DNA 
 
ICE AND DARKNESS DURING THE ASSAY! 
 
1. Mix in PCR-tube:   
 
bubbleU-DNA R-loopU-DNA 
1 μl  Cy3-54Ucenterbubble18 (100 pmol/μl)  
 
1 μl  Cy3-54Ucenterbubble18 (100 pmol/μl)  
 
2 μl complementary strand (54bub-
ble18comp, 100 pmol/μl)  
 
2 μl complementary strand (54bub-
ble18comp, 100 pmol/μl)  
 
 2 μl 18RNAfor54comp (100 pmol/μl) 
7 μl 1× Salt-Tris-EDTA (STE) buffer. 5 μl 1× Salt-Tris-EDTA (STE) buffer. 
 
2. Incubate at 95°C, 3 min (μg oligo) in the thermocycler.  
3. Use the thermocycler with the program 1degree. It employs the cooling with the rate of 
1°C per min for 2 h. 
4. Dilute with 90 μl 1× TE buffer to make 1 pmol/μl. Store at –4°C, in the dark.  
5. Verify the hybridization using the native PAGE with TBE.  
 
Buffers: 
Table 1. Activity assay mixture 
 
Buffers Composition (for 5×) Stock Mix prepa-
ration 
HEPES buffer (5×) 
(hSMUG1) 
 
225 mM HEPES, pH 7.5 1 M (lab stock) 22.5 ml 
10% glycerol 85% (Merck, Cat # 
1.04094) 
12 ml 
2 mM EDTA 0.5 M (lab stock) 400 µl 
Deionized H2O  to 100 ml 





100 mM Tris, pH 7.5 1 M (lab stock) 10 ml 
300 mM NaOH 3 M (lab stock) 10 ml 
5 mM EDTA 0.5 M (lab stock) 1 ml 
Deionized H2O  to 100 ml 
Tris-EDTA-glycerol 
buffer (5×) (hSMUG1) 
225 mM Tris-HCl, pH 7.5 1 M (lab stock) 5.625 ml 
10% glycerol 85% (Merck) 2.94 ml 
2 mM EDTA 500 mM EDTA 0.1 ml 
Deionized H2O  to 25 ml 
Stored at –20°C in aliquots. 
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Table 2. 96% ethanol with 0.1 M CH3COONa (for DNA precipitation) 
Composition Stock  Mix prepara-
tion 
0.1 M NaOAc  Sigma, Cat. # S2889, 82.03 
g/mol 
0.82 g 
96% EtOH 99.5% 225 µl 
Stored at room temperature. 
 
 
Table 3. 1 M KCl 
Composition Stock  Mix preparation 
1 M KCl  Sigma, Cat. # 5405, 74.55 g/mol 3.72 g 
Deionized H2O 96% 50 ml 
Stored at –20°C in aliquots. 
 
Table 4. Stop solution 
Composition Stock  Mix preparation 
20 mM EDTA  0.5 M (lab stock) 2 ml 
SDS, 0.5% (w/v)  99% (Sigma, Cat. # L3771, 
288.38 g/mol) 
252 mg 
Deionized H2O  to 50 ml 
Stored at room temperature. 
 
Table 5. Salt-TE (STE) buffer (for DNA oligomer hybridization) 
Composition Stock  Mix preparation 
10 mM Tris, pH 8.0 1 M 200 µl 
50 mM NaCl Sigma, Cat. # S5886, 58.44 g/mol 58.44 mg 
1 mM EDTA 0.5 M (lab stock) 40 µl 
Deionized H2O  to 20 ml 
Filtrated and stored in aliquots at –20°C. 
 
Table 6. Loading buffer (Note: no bromophenol blue) 
Composition Stock  Mix preparation 
Formamide, 80%  99.5% (Sigma, Cat. # F9037) 40.20 ml 
1 mM EDTA 0.5 M 100 µl 
Blue dextran, 1% (w/v)  Sigma, Cat. # D5751 0.5 g 
Deionized H2O  to 50 ml 
Stored at –20°C in aliquots. 
 
Table 7. TE buffer (1×) 
Composition Stock  Mix preparation 
10 mM Tris, pH 7.5 1 M 200 µl 
1 mM EDTA, pH 8.0, sterile filtrated 0.5 M 1.6 ml 
Deionized H2O  to 20 ml 




















Table 10. Denaturing 20% PAGE gel with urea 7 M (taurine buffer system) 
Composition Stock  Big gel Small gel 
Polyacrylamide, 20% (w/v) 40% (Saveen Werner AB, 
Cat. # BIAC21) 
12.5 ml 4.166 ml 
Taurine buffer (1×) Taurine (20×) (lab stock) 1.25 ml 416.6 µl 
Urea 99.5% (Sigma, Cat # F9037) 10.5 g 3.5 g 
Deionized H2O  3.75 ml 1.25 ml 
Ammonium persulfate 
(APS) 
BioRad, Cat. # 161-0700, 
228.2 g/mol 






Invitrogen Cat. # 15524-010 25 µl 8.33 µl 
 
Table 11. Denaturing 20% PAGE gel with urea 8 M (TBE buffer system) 
Composition Stock  Small gel 
Polyacrylamide, 20% (w/v) 40% (Saveen Werner AB, 
Cat. # BIAC21)  
3.5 ml 
TBE (1×) 10× TBE (lab stock) 700 µl 
Urea 99.5% (Sigma, Cat. # 
F9037) 
3.363 g 
Deionized H2O  280 µl 
Ammonium persulfate 
(APS) 
(BioRad, Cat. # 161-









Composition Stock  Mix prepara-
tion 
Tris base, 1.78 M  Sigma, Cat. # T6066, 121.14 g/mol 216 g 
Taurine, 0.58 M Sigma, Cat. # T0625, 125.15 g/mol 72 g 
Na2EDTA×2H2O Lab stock 4 g 
Deionized H2O  to 1000 ml 
Composition Stock  Mix preparation 
Tris base, 890 mM  Sigma, Cat. # T6066, 121.14 g/mol 108 g 
Boric acid, 890 mM  MW 61.8 55 g 
20 mM EDTA, pH 8 500 mM (lab stock) 40 ml 
Deionized H2O  to 1000 ml 
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Table 12. 20% acrylamide native PAGE (Taurine buffer system) 
Composition Stock  Small gel 
Polyacrylamide, 20% (w/v) 40% (Saveen Werner AB, 
Cat. # BIAC21) 
3.25 ml 
Taurine (1×)  Taurine (20×) (lab stock) 375 µl 
Deionized H2O  3.375 ml 
Ammonium persulfate 
(APS) 
(BioRad, Cat. # 161-








Table 13. Non-denaturing Loading buffer   
Composition Stock  Small gel 
10 mM Tris, pH 7.6  1 M   50 μl  
Taurine (1×)  Taurine (20×) (lab stock) 375 µl 
60% glycerol  85% (Merck, Cat #: 
1.04094)  
3.45 ml (from 87% prepared 
stock)  
60 mM EDTA  0.5 M (lab stock)  600 μl  
1% (w/v) blue dextran    0.05 g  



















































hSMUG1 S26R/E35D R-loopU-DNA 
 
 
 
